Shinji Harada

3.6k total citations · 2 hit papers
100 papers, 3.1k citations indexed

About

Shinji Harada is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Shinji Harada has authored 100 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 50 papers in Virology and 32 papers in Infectious Diseases. Recurrent topics in Shinji Harada's work include HIV Research and Treatment (50 papers), T-cell and Retrovirus Studies (35 papers) and Animal Disease Management and Epidemiology (30 papers). Shinji Harada is often cited by papers focused on HIV Research and Treatment (50 papers), T-cell and Retrovirus Studies (35 papers) and Animal Disease Management and Epidemiology (30 papers). Shinji Harada collaborates with scholars based in Japan, United States and Sweden. Shinji Harada's co-authors include Naoki Yamamoto, Yoshio Koyanagi, Mari Kannagi, Yosuke Maeda, Takao Masuda, Masakazu Hatanaka, Marcelo J. Kuroda, Keisuke Yusa, Nobuyuki Kobayashi and Hideki Nakashima and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Shinji Harada

100 papers receiving 3.0k citations

Hit Papers

Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 a... 1985 2026 1998 2012 1985 1991 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay
    1985 790 citations Shinji Harada, Yoshio Koyanagi et al. profile →
  2. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells
    1991 223 citations Mari Kannagi, Shinji Harada et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shinji Harada Japan 26 1.8k 1.5k 1.2k 583 579 100 3.1k
Jason T. Kimata United States 26 963 0.5× 1.1k 0.7× 678 0.6× 329 0.6× 417 0.7× 81 2.1k
Damian F. J. Purcell Australia 36 2.1k 1.2× 1.3k 0.9× 1.2k 1.0× 652 1.1× 126 0.2× 132 4.0k
Yoshiyuki Yoshinaka Japan 22 811 0.4× 498 0.3× 779 0.7× 363 0.6× 224 0.4× 53 2.3k
Alan Cochrane Canada 34 1.5k 0.8× 565 0.4× 932 0.8× 300 0.5× 145 0.3× 79 3.5k
Fei Guo China 32 1.5k 0.8× 1.3k 0.9× 1.6k 1.4× 868 1.5× 95 0.2× 100 4.1k
Florence Guivel‐Benhassine France 22 684 0.4× 1.1k 0.7× 1.7k 1.5× 519 0.9× 67 0.1× 35 3.1k
Timothy W. Baba United States 21 2.4k 1.3× 1.5k 1.0× 982 0.8× 1.0k 1.8× 56 0.1× 33 3.2k
Eberhard Pfaff Germany 34 230 0.1× 411 0.3× 519 0.4× 1.4k 2.4× 638 1.1× 80 3.7k
Michele A. Kutzler United States 25 460 0.3× 1.3k 0.9× 688 0.6× 583 1.0× 66 0.1× 61 2.5k
Bruce A. Mungall Australia 31 251 0.1× 209 0.1× 953 0.8× 1.6k 2.8× 283 0.5× 44 2.4k

Countries citing papers authored by Shinji Harada

Since Specialization
Citations

This map shows the geographic impact of Shinji Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Harada more than expected).

Fields of papers citing papers by Shinji Harada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinji Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Harada. The network helps show where Shinji Harada may publish in the future.

Co-authorship network of co-authors of Shinji Harada

This figure shows the co-authorship network connecting the top 25 collaborators of Shinji Harada. A scholar is included among the top collaborators of Shinji Harada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinji Harada. Shinji Harada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saito, Makoto, Makoto Ozawa, Shinji Harada, et al.. (2012). Genomic polymorphisms in 3β‐hydroxysterol Δ24‐reductase promoter sequences. Microbiology and Immunology. 57(3). 179–184. 8 indexed citations
3.
Ikeda, Terumasa, Takeo Ohsugi, Tetsuya Kimura, et al.. (2008). The antiretroviral potency of APOBEC1 deaminase from small animal species. Nucleic Acids Research. 36(21). 6859–6871. 37 indexed citations
4.
Maeda, Yosuke, Keisuke Yusa, & Shinji Harada. (2007). Altered sensitivity of an R5X4 HIV-1 strain 89.6 to coreceptor inhibitors by a single amino acid substitution in the V3 region of gp120. Antiviral Research. 77(2). 128–135. 14 indexed citations
5.
Tominaga, Masato, et al.. (2004). Sensitivity of chronically HIV-1 infected HeLa cells to electrical stimulation. Applied Microbiology and Biotechnology. 63(6). 754–758. 5 indexed citations
6.
Harada, Shinji. (2002). Human Immunodeficiency Virus Type 1 Neutralization by a Single Molecule of V3‐Targeted Antibody. Microbiology and Immunology. 46(12). 857–862. 2 indexed citations
7.
8.
Kannagi, Mari, Shuzo Matsushita, Hisatoshi Shida, & Shinji Harada. (1994). Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.. PubMed. 8 Suppl 1. S54–9. 30 indexed citations
9.
Masuda, Takao, Seiji Mita, Hirofumi Arakawa, et al.. (1992). Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines. International Journal of Clinical & Laboratory Research. 22(1-4). 216–219. 27 indexed citations
10.
Gyotoku, Jun-Ichiro, et al.. (1991). Inhibition of human immunodeficiency virus replication in a human T cell line by antisense RNA expressed in the cell. Virus Genes. 5(3). 189–202. 13 indexed citations
11.
Kubota, Satoshi, et al.. (1990). 2,3 Dimercapto-1-Propanol Inhibits HIV-1 tat Activity, Viral Production, and Infectivity In Vitro. AIDS Research and Human Retroviruses. 6(7). 919–927. 19 indexed citations
12.
Masuda, Takao, Sachiko Matsushita, Marcelo J. Kuroda, et al.. (1990). Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region.. The Journal of Immunology. 145(10). 3240–3246. 44 indexed citations
13.
Ohno, Tatsuharu, T Kanoh, Haruto Uchino, & Shinji Harada. (1988). Effect of immunoglobulin preparation on course of AIDS-related complex(ARC).. The Tohoku Journal of Experimental Medicine. 156(4). 415–416. 1 indexed citations
14.
Goto, Toshiyuki, Shinji Harada, Naoki Yamamoto, & Masuyo Nakai. (1988). Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line. Archives of Virology. 102(1-2). 29–38. 24 indexed citations
15.
Hamamoto, Yoshiaki, Shinji Harada, Naoki Yamamoto, et al.. (1987). Elimination of Viruses (Human Immunodeficiency, Hepatitis B,Vesicular Stomatitis and Sindbis Viruses) from an IntravenousImmunoglobulin Preparation. Vox Sanguinis. 53(2). 65–69. 1 indexed citations
16.
Harada, Shinji, Yoshio Koyanagi, & Naoki Yamamoto. (1985). Infection of human T-lymphotropic virus type-1 (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): Chronological studies of early events. Virology. 146(2). 272–281. 78 indexed citations
17.
Feusner, James H., Shinji Harada, Warren G. Sanger, et al.. (1984). Fatal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. The Journal of Pediatrics. 105(1). 64–67. 19 indexed citations
18.
Koyanagi, Yoshio, Susumu Kobayashi, Shinji Harada, et al.. (1983). DETECTION OF ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUSES TYPE I AND III IN JAPANESE HEMOPHILIACS. PubMed. 1(5). 353–358. 11 indexed citations
19.
Purtilo, David T., Shinji Harada, E Tatsumi, et al.. (1983). HUMAN T CELL LEUKEMIA VIRUS-1 ANTIBODIES NOT DETECTED IN AIDS. PubMed. 1(4). 237–241. 1 indexed citations
20.
Harada, Shinji, Thomas Bechtold, Janet K. Seeley, & David T. Purtilo. (1982). Cell‐mediated immunity to Epstein‐Barr virus (EBV) and natural killer (NK)‐cell activity in the X‐linked lymphoproliferative syndrome. International Journal of Cancer. 30(6). 739–744. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason T. Kimata Breakdown of academic impact, for papers by Damian F. J. Purcell Breakdown of academic impact, for papers by Yoshiyuki Yoshinaka Breakdown of academic impact, for papers by Alan Cochrane Breakdown of academic impact, for papers by Fei Guo Breakdown of academic impact, for papers by Florence Guivel‐Benhassine Breakdown of academic impact, for papers by Timothy W. Baba Breakdown of academic impact, for papers by Eberhard Pfaff Breakdown of academic impact, for papers by Michele A. Kutzler Breakdown of academic impact, for papers by Bruce A. Mungall
Rankless by CCL
2026